Gender difference in motor impairments induced by chronic administration of vinblastine

Iranian Journal of Basic Medical Sciences

Volumn 17, Issue 6, 2014, Pages 433-440

  Parsania, Shahrnaz ^a   Shabani, Mohammad ^b   Moazzami, Kasra ^c   Razavinasab, Moazamehosadat ^a   Larizadeh, Mohammad Hassan ^d   Nazeri, Masoud ^e   Asadi Shekaari, Majid ^b   Kermani, Moein ^e  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticancer; Learning and memory; Motor function; Vinblastine

Indexed keywords

VINBLASTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BODY MASS; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; GRASPING TEST; HIPPOCAMPUS; HISTOLOGY; LOW DRUG DOSE; MALE; MEMORY; MORRIS WATER MAZE TEST; MOTOR DYSFUNCTION; NEUROTOXICITY; NONHUMAN; OPEN FIELD TEST; RAT; ROTAROD TEST; SEX DIFFERENCE; SPATIAL LEARNING;

EID: 84903382424     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Correa DD, Ahles TA. Neurocognitive changes in cancer survivors. Cancer J 2008; 14:396-400.
2. Liang GW, Lu WL, Wu JW, Zhao JH, Hong HY, Long C, et al. Enhanced therapeutic effects on the multidrug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine. Fundam Clin Pharmacol 2008; 22:429-437.
3. Tin SNW, Martin-Duverneuil N, Idbaih A, Garel C, Ribeiro M, Parker JL, et al. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study. Orphanet J Rare Dis 2011; 6:83.
4. Shabani M, Larizadeh MH, Parsania S, Asadi-shekaari M, Shahrokhi N. Profound destructive effects of adolescent exposure to vincristine accompanied with some sex differences in motor and memory performance. Can J Physiol Pharmacol 2012; 90:379-386.
5. Steward O, Goldschmidt RB, Sutula T. IV. Neurotoxicity of colchicine and other tubulin-binding agents: A selective vulnerability of certain neurons to the disruption of microtubules. Life Sci 1984; 35:43-51.
6. Kruczynski A, Hill BT. Vinflunine, the latest Vinca alkaloid in clinical development:: A review of its preclinical anticancer properties. Crit Rev Oncol Hematol 2001; 40:159-173.
7. Kruczynski A, Barret JM, Etiãvant C, Colpaert F, Fahy J, Hill BT. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. Biochem Pharm 1998; 55:635-648.
8. Suman G, Jamil K. Application of human lymphocytes for evaluating toxicity of anti-cancer drugs. Int J Pharmacol 2006; 2:374-381.
9. Martinez FJ, Zeng GQ, Piñeyro A, Garza-Ocañas L, Tomei LD, Umansky SR. Apoptosis induction and cell cycle perturbation in established cell lines by peroxysomicine A1 (T-514) 1 Drug Chem Toxicol 2001; 24:287-299.
10. Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FSAM, et al. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 2008; 186:168-175.
11. Shabani M, Larizadeh Mh, Parsania S, Hajali V, Shojaei A. Evaluation of destructive effects of exposure to cisplatin during developmental stage: No profound evidence for sex differences in impaired motor and memory performance. Int J Neurosci 2012; 22:439-448.
12. Argyriou A, Polychronopoulos P, Koutras A, Xiros N, Petsas T, Argyriou K, et al. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel based chemotherapy. Eur J Cancer Care 2007; 16:231-237.
13. Yalcin S NG, Orhan B, Zeybek D, Müftüoǧlu S, Sarer B, Yildirim BA, et al. Protective effect of amifostine against cisplatin-induced motor neuropathy in rat. Med Oncol 2003; 20:175-180.
14. Van Wijk N, Rijntjes E, Van De Heijning B. Perinatal and chronic hypothyroidism impair behavioural development in male and female rats. Exp Physiol 2008; 93:1199-1209.
15. Haghani M, Shabani M, Moazzami K. Maternal mobile phone exposure adversely affects the electrophysiological properties of Purkinje neurons in rat offspring. Neuroscience 2013; 250:588-598.
16. Shabani M, Haghani M, Shaibani V, Janahmadi M. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurones in rat offspring. Neuroscience 2011; 172:139-152.
17. Golchin L, Vahidi A, Shabani M. Hippocampus and cerebellum function following imipenem treatment in male and female rats: evaluation of sex differences during developmental stage. Pak J Biol Sci 2013; 16:151-159.
18. Razavinasab M, Shamsizadeh A, Shabani M, Nazeri M, Allahtavakoli M, Asadi-Shekaari M, Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease. Fundam Clin Pharmacol 2013; 27:632-640.
19. de Souza Lisboa SF, Gonçalves G, Komatsu F, Salci Queiroz CA, Aparecido Almeida A, Gastaldello Moreira E. Developmental lead exposure induces depressive-like behavior in female rats. Drug Chem Toxicol 2005; 28:67-77.
20. Shojaei A, Shabani M, Pilevarian A, Parsania S, Razavinasab M. Effect of acute administration of Cisplatin on memory, motor learning, balance and explorative behaviours in Rats. Physiol Pharmacol 2012; 16:121-135.
21. Frick KM, Stillner ET, Berger-Sweeney J. Mice are not little rats: species differences in a one-day water maze task. Neuroreport 2000; 11:3461.
22. Azimi L, Pourmotabbed A, Ghadami MR, Nedaei SE, Pourmotabbed T. Effects of peripheral and Intra-hippocampal administration of sodium salicylate on spatial learning and memory of rats. Iran J Basic Med Sci 2012; 15:709.
23. Movassaghi S, Sharifi ZN, Soleimani M, Joghataii MT, Hashemi M, Shafaroodi H, et al. Effect of pentoxifylline on ischemia-induced brain damage and spatial memory impairment in rat. Iran J Basic Med Sci 2012; 15:1083-1090.
24. Wright M, Garès M, Verdier-Pinard P, Moisand A, Berlion M, Legrand JJ, et al. Differential in vitro action of S-12363, a new vinblastine derivative, and of its epimer on microtubule proteins. Cancer Chemother Pharmacol 1991; 28:434-440.
25. Gozdz A, Habas A, Jaworski J, Zielinska M, Albrecht J, Chlystun M, et al. Role of N-methyl-D-aspartate receptors in the neuroprotective activation of extracellular signal-regulated kinase 1/2 by cisplatin. J Biol Chem 2003; 278:43663-43671.
26. Park DS, Morris EJ, Stefanis L, Troy CM, Shelanski ML, Geller HM, et al. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci 1998; 18:830-840.
27. Souid A-K, Tacka KA, Galvan KA, Penefsky HS. Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem Pharmacol 2003; 66:977-987.
28. Zhou B-BS, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408:433-439.
29. Goldschmidt R, Steward O. Comparison of the neurotoxic effects of colchicine, the vinca alkaloids, and other microtubule poisons. Brain Res 1989; 486:133-140.
30. Shabani M, Haghani M, Sheibani V, Janahmadi M. Changes in motor and learning behaviors of rats prenatally exposed to WIN 55212-2, a cannabinoid receptor agonist. Physiol Pharmacol 2009; 13:120-129.
31. Razavinasab M, Shamsizadeh A, Shabani M, Nazeri M, Allahtavakoli M, Asadi-Shekaari M, et al. Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease. Fundam Clin Pharmacol 2012; 27: 632-640.
32. Joseph EK, Levine JD. Sexual dimorphism for protein kinasec signaling in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience 2003; 119:831-838.
33. Snell RS. Clinical neuroanatomy: Lippincott Williams & Wilkins; 2009.
34. Wang J, Huang Y. Pharmacogenomics of sex difference in chemotherapeutic toxicity. Curr Drug Discov Technol 2007; 4:59-68.
35. Allen JS, Damasio H, Grabowski TJ, Bruss J, Zhang W. Sexual dimorphism and asymmetries in the gray-white composition of the human cerebrum. Neuroimage 2003; 18:880-894.
36. Madeira MD, Lieberman AR. Sexual dimorphism in the mammalian limbic system. Prog Neurobiol 1995; 45:275-333.
37. Reza E, Nezhad H, Kamyab S, Center B, Center SO. Consequences of Ischemic Preconditioning of Kidney: Comparing between male and female rats. Iran J Basic Med Sci 2012; 15: 1148-1153.
38. Turner BB, Weaver DA. Sexual dimorphism of glucocorticoid binding in rat brain. Brain Res 1985; 343:16-23.
39. Valencia-Sánchez A, Esparza-Avalos N, Cruz M, Ortega-Corona B. Amine neurotransmitter levels in male and female rats through developmental periods. Arch Androl 1997; 39:79-83.
40. Waber DP, Gioia G, Paccia J, Sherman B, Dinklage D, Sollee N, et al. Sex differences in cognitive processing in children treated with CNS prophylaxis for acute lymphoblastic leukemia. J Pediatr Psychol 1990; 15:105-122.